Head to head for first-timers
CoreAge Rx vs MEDVi
CoreAge Rx and MEDVi both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #1 for first-timers · Grade A
Mama-Match
Best for: Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Visit CoreAge RxMEDVi
Rank #218 for first-timers · Grade C
Mama-Match
Best for: A reader comparing brand access and named pharmacies, who is going to weigh the FDA warning letter before anything else.
Visit MEDViThe verdict for a first step
CoreAge Rx edges out MEDVi on the Mama-Match Score, 94 to 49 (A vs C). Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
MEDVi is still a genuine option — ⛔ Carries an FDA warning letter for a misbranded compounded product (#721455, February 2026). It names its pharmacies with addresses, but publishes only the first month's price. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | MEDVi |
|---|---|---|
| Mama-Match Score | 94/100 · A | 49/100 · C |
| Overall rank | #1 | #218 |
| Semaglutide | $99/mo | From $179 the first month; no ongoing rate published |
| Tirzepatide | $149/mo | No compounded tirzepatide price on its public page |
| Coverage | All 50 states | No state list on the GLP-1 page |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Mama-Match
CoreAge Rx
Rank #1 · Grade A
What we like
- One flat monthly price, with no teaser rate that jumps after the first month — you know the number before you commit
- A clinician reads your history and will genuinely talk timing with you if you're postpartum, breastfeeding, or trying to conceive
- Semaglutide and tirzepatide in one account, so you and a clinician can choose — and switch — without starting over
The caveats
- Not the rock-bottom teaser price — a couple of marketplaces dangle a lower first-month number
- Compounded medication only, not FDA-approved brand-name Ozempic or Wegovy
- A general metabolic program, not a dedicated OB-GYN or hormone consult
Mama-Match
MEDVi
Rank #218 · Grade C
What we like
- Names its partner pharmacies with address and phone: Triad Rx in Daphne, Alabama, and RedRock Pharmacy in St. George, Utah
- Names the company in its privacy policy: MEDVi, LLC, a Delaware corporation, in Newark
- Offers FDA-approved brand medication — Wegovy in pill and injection, and Zepbound — alongside the compounded product
The caveats
- ⛔ FDA warning letter #721455, dated February 20, 2026, to MEDVi, LLC, for false or misleading claims and a misbranded compounded product
- ⛔ Publishes only "from $179" for the first month; the ongoing rate is nowhere on the page
- "No membership or hidden fees!" sits on the same page as three brand options costing "$99 membership + medication cost"
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and MEDVi with the other providers we review for women.
Or browse the full comparison hub.